MiR-491-5p has been demonstrated both in vitro and in vivo to exert a pro-tumoral role also in glioblastoma, by reducing the sensitivity of glioblastoma cells to ferroptosis through the inhibition of the p53/p21 signaling pathway45. This evidence concerns the gene TP53 and glioblastoma.